What is HYPD's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.05B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for HYPD?

P/E (TTM) is 6.66 and 52-week range is $2.34 to $9.13 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s HYPD figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for HYPD?

The company profile lists revenue (TTM) near $1M, net income (TTM) near $6M, EPS (TTM) near -$2.10 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Hyperion DeFi Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Dallas, Texas, US, 15.2M shares outstanding, ISIN US30234E2037 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Hyperion DeFi Inc

$HYPD

Health Care · Pharmaceuticals

IR Run Scenarios

Overview Charts AI Summary Financials Valuation

Profile

Read AI summary

Hyperion DeFi, Inc. is a long-term strategic treasury of Hyperliquid’s native token HYPE. The company is headquartered in Dallas, Texas and currently employs 9 full-time employees. The company went IPO on 2018-01-25. The firm is focused on providing simplified access to the Hyperliquid ecosystem. The company is also developing its proprietary Optejet User Filled Device (UFD) that is designed to work with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The Optejet is useful in chronic front-of-the-eye diseases due to its ease of use, enhanced safety and tolerability, and potential for superior compliance versus standard eye drops. Together, these benefits may result in higher treatment compliance and better outcomes for patients and providers. The company has launched its cryptocurrency treasury reserve, which is native to the decentralized digital asset exchange and Layer-1 blockchain, Hyperliquid. Hyperliquid is a layer one blockchain (L1) written and optimized from first principles.

Employees

Website

hyperiondefi.com/

IPO

2018-01-25

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NASDAQ NMS - GLOBAL MARKET

ISIN

US30234E2037

Headquarters

Dallas, Texas, US

Shares outstanding

15.2M

NAICS sector

Manufacturing

Institutional ownership

18.00%

Browse other companiesFree AI scores and summaries for more stocks